← Browse by Condition
Medical Condition

hemorrhage

Total Trials
5
Recruiting Now
5
Trial Phases
EARLY_Phase 1, Phase 3

ClinicalMetric tracks all active clinical trials for hemorrhage sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — hemorrhage Clinical Trials

How many clinical trials are currently recruiting for hemorrhage?
ClinicalMetric currently tracks 5 actively recruiting clinical trials for hemorrhage, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 5. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for hemorrhage?
hemorrhage research spans Phase 1 (1 trial), Phase 3 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a hemorrhage clinical trial?
Eligibility criteria for hemorrhage trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 1
1
Phase 3
1
Top Sponsors
University of Minnesota 1 trial
University Hospital Center of Martinique 1 trial
Boston Children's Hospital 1 trial
Corza Medical GmbH 1 trial
University Medical Center Groningen 1 trial

Recruiting Clinical Trials

NCT06345833 EARLY_Phase 1
Recruiting

Topical and Local TXA in Facelifts - A Randomized Controlled Double Blinded Study

Enrollment
50 pts
Location
United States
Sponsor
University of Minnesota
View Trial →
NCT06304714
Recruiting

Effects of Bothrops Spp. Snake Envenomation on Willebrand Factor Activity in Martinique and French Guiana

Enrollment
30 pts
Location
Martinique
Sponsor
University Hospital Center of ...
View Trial →
NCT02601339
Recruiting

NIRS Monitoring in Premature Infants

Enrollment
70 pts
Location
United States
Sponsor
Boston Children's Hospital
View Trial →
NCT06664775 Phase 3
Recruiting

A Study to Compare the Efficacy and Safety of TachoSil and Surgicel Original as an Adjunct to Control Mild to Moderate Soft Tissue Bleeding During Surgery

Enrollment
116 pts
Location
United States
Sponsor
Corza Medical GmbH
View Trial →
NCT04615065
Recruiting

Acutelines: a Large Data-/Biobank of Acute and Emergency Medicine

Enrollment
35,000 pts
Location
Netherlands
Sponsor
University Medical Center Gron...
View Trial →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology